E-LIB Suche - Ergebnisse für: Hirst, Gavin C

1

Discovery of a Gut-Restricted JAK Inhibitor for the Treatme..:

Leonard, Kristi A. ; Madge, Lisa A. ; Krawczuk, Paul J....
Journal of Medicinal Chemistry. 63 (2020) 6 - p. 2915-2929 , 2020

Link: https://doi.org/10.1021/..

2

Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (R..:

Hecker, Scott J. ; Reddy, K. Raja ; Totrov, Maxim...
Journal of Medicinal Chemistry. 58 (2015) 9 - p. 3682-3692 , 2015

Link: https://doi.org/10.1021/..

3

Discovery of thienopyridines as Src-family selective Lck in..:

Abbott, Lily ; Betschmann, Patrick ; Burchat, Andrew...
Bioorganic & Medicinal Chemistry Letters. 17 (2007) 5 - p. 1167-1171 , 2007

Link: https://doi.org/10.1016/..

4

Discovery of A-770041, a src-family selective orally active..:

Burchat, Andrew ; Borhani, David W. ; Calderwood, David J....
Bioorganic & Medicinal Chemistry Letters. 16 (2006) 1 - p. 118-122 , 2006

Link: https://doi.org/10.1016/..

5

Suppression of CD4+ T cell activation by a novel inhibitor ..:

McRae, Bradford L. ; Wallace, Craig ; Dixon, Kathleen Fitzgerald...
International Immunopharmacology. 5 (2005) 4 - p. 667-677 , 2005

Link: https://doi.org/10.1016/..

6

Utilization of Microarrayed Compound Screening (μARCS) to I..:

Freiberg, Gail ; Wilkins, Julie ; David, Caroline...
SLAS Discovery. 9 (2004) 1 - p. 12-21 , 2004

Link: https://doi.org/10.1177/..

7

A-420983: a potent, orally active inhibitor of lck with eff..:

Borhani, David W. ; Calderwood, David J. ; Friedman, Michael M....
Bioorganic & Medicinal Chemistry Letters. 14 (2004) 10 - p. 2613-2616 , 2004

Link: https://doi.org/10.1016/..

8

Pyrazolo[3,4-d]pyrimidines containing an extended 3-substit..:

Burchat, Andrew F. ; Calderwood, David J. ; Friedman, Michael M....
Bioorganic & Medicinal Chemistry Letters. 12 (2002) 12 - p. 1687-1690 , 2002

Link: https://doi.org/10.1016/..

9

Pyrrolo[2,3-d]pyrimidines Containing an Extended 5-Substitu..:

Burchat, Andrew F ; Calderwood, David J ; Hirst, Gavin C...
Bioorganic & Medicinal Chemistry Letters. 10 (2000) 19 - p. 2171-2174 , 2000

Link: https://doi.org/10.1016/..

10

Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepin..:

Henke, Brad R. ; Aquino, Christopher J. ; Birkemo, Larry S....
Journal of Medicinal Chemistry. 40 (1997) 17 - p. 2706-2725 , 1997

Link: https://doi.org/10.1021/..

11

Conversion of acyclic nonpeptide CCK antagonists into CCK a..:

Hirst, Gavin C. ; Queen, Kennedy L. ; Sugg, Elizabeth F..
Bioorganic & Medicinal Chemistry Letters. 7 (1997) 5 - p. 511-514 , 1997

Link: https://doi.org/10.1016/..

12

Discovery of 1,5-Benzodiazepines with Peripheral Cholecysto..:

Aquino, Christopher J. ; Armour, Duncan R. ; Berman, Judd M....
Journal of Medicinal Chemistry. 39 (1996) 2 - p. 562-569 , 1996

Link: https://doi.org/10.1021/..

13

Discovery of 1,5-Benzodiazepines with Peripheral Cholecysto..:

Hirst, Gavin C. ; Aquino, Christopher ; Birkemo, Lawrence...
Journal of Medicinal Chemistry. 39 (1996) 26 - p. 5236-5245 , 1996

Link: https://doi.org/10.1021/..

14

Comparison of in silico strategies to prioritize rare genom..:

Rowlands, Charlie ; Thomas, Huw B. ; Lord, Jenny...
Scientific Reports. 11 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

15

SNVMix: predicting single nucleotide variants from next-gen..:

Goya, Rodrigo ; Sun, Mark G.F. ; Morin, Ryan D....
Bioinformatics. 26 (2010) 6 - p. 730-736 , 2010

Link: https://doi.org/10.1093/..